antibluechip, These are all good questions for our legal experts. I don’t have any educated answers for you. I personally feel that the infringement angle is the best way to effect change.
ABC, The ab rating given to the generic version of Vascepa should insulate insurance companies from that type of liability. The ab rating implies that the drugs are identical. At least in the view of the FDA. gv doesn't have a CVD label, that is a patent issue. Sleven,